$28.78
-0.90 (-3.03%) today
Urogen Pharma Ltd (URGN) is up 192.2% over the past year and 33.80% over the past month, trading at $28.78.
Price · today
Key stats
Market cap$1.45B
Day high$29.59
Day low$28.26
Day open$29.26
Prev close$29.68
ExchangeNASDAQ NMS - GLOBAL MARKET
Performance · all intervals
1D
-3.03%
1W
-2.11%
1M
+33.80%
3M
+43.18%
6M
+21.13%
YTD
+22.89%
1Y
+192.18%
5Y
+80.33%
ALL
+105.57%
Green vs red closes
Last 1D
0up1down
0% green
Last 1W
2up3down
40% green
Last 1M
13up9down
59% green
Last 3M
30up33down
48% green
Last 6M
57up66down
46% green
Year to date
43up49down
47% green
Last 1Y
124up125down
50% green
Last 5Y
589up651down
48% green
Custom Interval
Pick any window — not just the presets above.
days
Related stocks
Compare URGN with
Latest news on URGN
UroGen Announces That UGN-103 Achieved A 94.5% Durability Of Response At Six Months In The Ongoing Phase 3 UTOPIA Trial For Intravesical Solution In Patients With Bladder Cancer
Benzinga·1d ago
UroGen Reports 94.5% Six-Month Duration of Response in Phase 3 UTOPIA Trial, Advancing UGN-103 Toward Potential Approval in Recurrent Low-Grade Intermediate-Risk NMIBC
Finnhub·1d ago
UroGen Pharma Ltd. (URGN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
SeekingAlpha·2d ago
Transcript : UroGen Pharma Ltd. Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 08
Finnhub·2d ago
UroGen Pharma Announces 36-Month Duration Of Response By Kaplan-Meier Estimate In Patients Who Achieved Complete Response At Three Months In Pivotal Phase 3 ENVISION Trial Of ZUSDURI For Intravesical Solution.
Benzinga·3d ago
Reserved